英和和英

名詞

baricitinib (uncountable)

1. (pharmacology) A medication belonging to the class of Janus kinase inhibitors, used for the treatment of several diseases including rheumatoid arthritis and COVID-19.
   • 2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2168:

     Baricitinib, a JAK1/JAK2 inhibitor, is approved for patients with RA in the US, with a dosage limited to 2 mg every day in combination with a csDMARD, or as monotherapy in patients with RA refractory to a bDMARD, based on phase III trial results.